5thPort™, the best-in-class cloud-based patient engagement and eConsent solution, announces significant enhancements in its latest release for clinical trials and healthcare providers.
5thPort™ to Exhibit at Future Trials Conference: Decentralized, Direct to Patient & Clinical Research
5thPort™ is excited to exhibit at the Future Trials Conference scheduled for June 22, 2021.
5thPort™ is excited to partner with the Court Square Group to help life science companies streamline clinical trials and improve outcomes.
Dr. Rob Berube of 5thPort™ to Participate in Panel Discussion at Michigan Health Information Network’s Virtual Conference
Dr. Rob Berube, co-founder of 5thPort™, will participate in a panel discussion facilitated by the Michigan Health Information Network (MiHIN).
5thPort™ is excited to exhibit at Clinical Trials Ontario (CTO) 2021's virtual conference, scheduled for March 23, 24, and 25, 2021.
5thPort Simplifies Adoption of eConsent Technology with FDA 21 [...]
Long Live Decentralized Trials Massive disruption from COVID-19 is [...]
In our continued commitment to helping our clients satisfy their audit requirements, we're pleased to announce that the 5thPort eConsent and patient engagement platform has been certified as compliant with FDA 21 CFR Part 11 & EU's EUDRALEX ANNEX 11.
8 Common Misconceptions About Clinical Trials Clinical trials are [...]
7 Steps to Improve Participant Retention in Clinical Trials [...]